Skip to main content
OpenTrials

Clinical trial condition

Hypercholesterolemia

Explore clinical trials studying Hypercholesterolemia. Study availability and eligibility vary by location and protocol.

723 public trials 20 recruiting studies
Refine in advanced search Browse all conditions

Hypercholesterolemia trial results

Active, not recruiting

Treatment With Bempedoic Acid and/or Its Fixed-dose Combination With Ezetimibe in Primary Hypercholesterolemia or Mixed Dyslipidemia

NCT04579367

Conditions
Dyslipidemias, Hypercholesterolemia, Hyperlipidemias, +4 more
Locations
  • Dr. Armin Öhlinger Kardiologe & innere Medizin Dornbirn, Austria
  • Landeskrankenhaus Feldkirch Feldkirch, Austria
  • LKH-Univ. Klinikum Graz Graz, Austria
  • Medizinische Universität Graz Graz, Austria
View all 443 locations
View Trial Details
Active, not recruiting

Study of Efficacy and Safety of Inclisiran in Asian Participants With Atherosclerotic Cardiovascular Disease (ASCVD) or ASCVD High Risk and Elevated Low Density Lipoprotein Cholesterol (LDL-C)

NCT04765657

Conditions
Dyslipidemias, Hypercholesterolemia, Hyperlipidemias, +3 more
Locations
  • Novartis Investigative Site Lanzhou, Gansu, China
  • Novartis Investigative Site Foshan, Guangdong, China
  • Novartis Investigative Site Guangzhou, Guangdong, China
  • Novartis Investigative Site Shijiazhuang, Hebei, China
View all 45 locations
View Trial Details
Active, not recruiting

Open-label Extension Study of Enlicitide Decanoate (MK-0616/Enlicitide Oral PCSK9 Inhibitor) in Adults With Hypercholesterolemia (MK-0616-019) CORALreef Extension

NCT06492291

Conditions
Dyslipidemias, Hypercholesterolemia, Hyperlipidemias, +3 more
Locations
  • Alliance for Multispecialty Research, LLC ( Site 0027) Daphne, Alabama, United States
  • G&L Research ( Site 0035) Foley, Alabama, United States
  • Synexus Clinical Research US, Inc.-Synexus Clinical Research US, Inc - Central Phoenix ( Site 0048) Phoenix, Arizona, United States
  • National Heart Institute-Research ( Site 0029) Beverly Hills, California, United States
View all 222 locations
View Trial Details
Completed

A Non-interventional Implementation Study to Evaluate Treatment With Inclisiran (Leqvio®) and Other Lipid Lowering Treatments in a Real-world Setting

NCT05362903

Conditions
Arterial Occlusive Diseases, Arteriosclerosis, Atherosclerosis, +8 more
Locations
  • Novartis Investigative Site Freudenstadt, Baden-Wurttemberg, Germany
  • Novartis Investigative Site Heidelberg, Baden-Wurttemberg, Germany
  • Novartis Investigative Site Kirchheim unter Teck, Baden-Wurttemberg, Germany
  • Novartis Investigative Site Konstanz, Baden-Wurttemberg, Germany
View all 121 locations
View Trial Details
Completed

A Study of Enlicitide Decanoate (MK-0616 Oral PCSK9 Inhibitor) in Adults With Hypercholesterolemia (MK-0616-013) CORALreef Lipids

NCT05952856

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dyslipidemias, Familial Hypercholesterolemia, +10 more
Locations
  • Alliance for Multispecialty Research, LLC ( Site 0093) Daphne, Alabama, United States
  • G&L Research ( Site 0043) Foley, Alabama, United States
  • Synexus Clinical Research US, Inc.-Synexus Clinical Research US, Inc - Central Phoenix ( Site 0084) Phoenix, Arizona, United States
  • National Heart Institute-Research ( Site 0087) Beverly Hills, California, United States
View all 168 locations
View Trial Details

Related conditions